Low Molecular Weight Heparin Market Scope And Analysis

Report Code : TIPRE00026174
Category : Life Sciences

Status : Published
No. of Pages : 191

Buy Now

Low Molecular Weight Heparin Market Analysis Report 2021-2031

Buy Now

Low Molecular Weight Heparin Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 3.66 Billion
Market Size by 2028	US$ 5.73 Billion
Global CAGR (2021 - 2028)	6.6%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Product Type Enoxaparin Dalteparin Tinzaparin Fraxiparine Nadroparin By Packaging Multi-Vials and Prefilled Syringes By Application Deep Vein Thrombosis Acute Coronary Syndrome Pulmonary Embolism By End User Hospitals Clinics Ambulatory Surgical Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Aspen Holdings Changzhou Qianhong Bio pharma LEOPHARMA A S Teva Pharmaceutical Industries Ltd B Braun Medical Inc Pfizer Inc Sanofi Aventis Dr Reddy s Laboratories Limited Abbott

COVID Impacts

The spread of the COVID-19 pandemic has emphasized health data sharing and interoperability under the microscope. The infection of novel coronavirus in children is mild compared to adults, and children are assigned a better prognosis. The interruptions in the supply chain and the massive demand for efficient treatments for COVID-19 have put the health research industry in Asia-Pacific in a crucial position.

Company Profiles

Aspen Holdings
Changzhou Qianhong Bio-Pharma
Leopharma A/S
Teva Pharmaceutical Industries Ltd.
B. Braun Medical, Inc.
Pfizer, Inc.
Sanofi
Dr. Reddy's Laboratories Limited
Abbott
Novartis AG